[HTML][HTML] Systematic review and subgroup meta-analysis of randomized trials to determine tocilizumab's place in COVID-19 pneumonia
T Klopfenstein, V Gendrin, A Gerazime… - Infectious diseases and …, 2021 - Springer
Introduction Tocilizumab randomized clinical trial results are heterogeneous because of the
heterogenous population included in them. Methods We conducted a meta-analysis with …
heterogenous population included in them. Methods We conducted a meta-analysis with …
Systematic Review and Subgroup Meta-analysis of Randomized Trials to Determine Tocilizumab's Place in COVID-19 Pneumonia.
T Klopfenstein, V Gendrin, A Gerazime… - Infectious Diseases …, 2021 - europepmc.org
Methods We conducted a meta-analysis with subgroup meta-analysis (PRISMA guidelines)
between severe and non-severe COVID-19. Results We included nine trials. Overall, the …
between severe and non-severe COVID-19. Results We included nine trials. Overall, the …
Systematic Review and Subgroup Meta-analysis of Randomized Trials to Determine Tocilizumab's Place in COVID-19 Pneumonia
T Klopfenstein, V Gendrin, A Gerazime… - Infectious Diseases …, 2021 - search.proquest.com
Methods We conducted a meta-analysis with subgroup meta-analysis (PRISMA guidelines)
between severe and non-severe COVID-19. Results We included nine trials. Overall, the …
between severe and non-severe COVID-19. Results We included nine trials. Overall, the …
[PDF][PDF] Systematic Review and Subgroup Meta-analysis of Randomized Trials to Determine Tocilizumab's Place in COVID-19 Pneumonia
T Klopfenstein, VGAGT Conrozier, JC Balblanc… - 2021 - scholar.archive.org
Introduction: Tocilizumab randomized clinical trial results are heterogeneous because of the
heterogenous population included in them. Methods: We conducted a meta-analysis with …
heterogenous population included in them. Methods: We conducted a meta-analysis with …
Systematic Review and Subgroup Meta-analysis of Randomized Trials to Determine Tocilizumab's Place in COVID-19 Pneumonia
T Klopfenstein, V Gendrin… - Infectious diseases …, 2021 - pubmed.ncbi.nlm.nih.gov
Introduction Tocilizumab randomized clinical trial results are heterogeneous because of the
heterogenous population included in them. Methods We conducted a meta-analysis with …
heterogenous population included in them. Methods We conducted a meta-analysis with …
[HTML][HTML] Systematic Review and Subgroup Meta-analysis of Randomized Trials to Determine Tocilizumab's Place in COVID-19 Pneumonia
T Klopfenstein, V Gendrin, A Gerazime… - Infectious Diseases …, 2021 - ncbi.nlm.nih.gov
Methods We conducted a meta-analysis with subgroup meta-analysis (PRISMA guidelines)
between severe and non-severe COVID-19. Results We included nine trials. Overall, the …
between severe and non-severe COVID-19. Results We included nine trials. Overall, the …
Systematic Review and Subgroup Meta-analysis of Randomized Trials to Determine Tocilizumab's Place in COVID-19 Pneumonia.
T Klopfenstein, V Gendrin, A Gerazime… - … Diseases & Therapy, 2021 - search.ebscohost.com
Introduction: Tocilizumab randomized clinical trial results are heterogeneous because of the
heterogenous population included in them. Methods: We conducted a meta-analysis with …
heterogenous population included in them. Methods: We conducted a meta-analysis with …